In this episode of 'Talking About Glaucoma,' host Rob Schertzer, a Vancouver-based glaucoma specialist, chats with guest Gavin Docherty about the evolving understanding of preservative-free therapies in glaucoma management. They discuss the historical rationale for including preservatives in eye drops and the recent studies showing that preservative-free options are equally effective while reducing side effects such as hyperemia, burning, and irritation. The conversation covers the benefits of preservative-free drops in terms of improving patient compliance and minimizing ocular surface damage, which could potentially lead to fewer surgeries and better outcomes. They also share clinical experiences and highlight the barriers to transitioning patients to preservative-free medications, including issues related to cost, accessibility, and environmental waste. The episode concludes with an emphasis on the importance of collaboration among eye care providers to enhance patient care.
All content for Talking About Glaucoma (mp3) is the property of Robert M Schertzer, MD, MEd, FRCSC and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of 'Talking About Glaucoma,' host Rob Schertzer, a Vancouver-based glaucoma specialist, chats with guest Gavin Docherty about the evolving understanding of preservative-free therapies in glaucoma management. They discuss the historical rationale for including preservatives in eye drops and the recent studies showing that preservative-free options are equally effective while reducing side effects such as hyperemia, burning, and irritation. The conversation covers the benefits of preservative-free drops in terms of improving patient compliance and minimizing ocular surface damage, which could potentially lead to fewer surgeries and better outcomes. They also share clinical experiences and highlight the barriers to transitioning patients to preservative-free medications, including issues related to cost, accessibility, and environmental waste. The episode concludes with an emphasis on the importance of collaboration among eye care providers to enhance patient care.
Ep 23 Talking About Glaucoma - 3Nov2014: ab-interno trabecular bypass surgery (mp3 version)
Talking About Glaucoma (mp3)
15 minutes 40 seconds
11 years ago
Ep 23 Talking About Glaucoma - 3Nov2014: ab-interno trabecular bypass surgery (mp3 version)
[This is the .mp3 un-enhanced version of this podcast. The AAC .m4a version has chapter markers and artwork embedded in the podcast to enhance the experience on devices/apps that support this, which includes most podcasting apps on iOS and Android devices. It is the preferred version for experiencing this podcast.] In this episode, Tom Samuelson and I discuss trabecular bypass procedures including the currently available & two future models of the iStent, and the Ivantis Hydrus Microstent. There is a tendency for doctors to prescribe third and fourth glaucoma medications even though it is well known that there is such a diminishing return after two medications. These ab-interno devices can serve as a glaucoma-lite procedure, the next step after two medications for those reluctant to proceed with a potentially more effective but more risky trabeculectomy. The use of multiple iStents, next generation devices, or targeting delivery to visualized collector ducts should lead to improvements in ab-interno trabecular bypass procedures in the years ahead.
Talking About Glaucoma (mp3)
In this episode of 'Talking About Glaucoma,' host Rob Schertzer, a Vancouver-based glaucoma specialist, chats with guest Gavin Docherty about the evolving understanding of preservative-free therapies in glaucoma management. They discuss the historical rationale for including preservatives in eye drops and the recent studies showing that preservative-free options are equally effective while reducing side effects such as hyperemia, burning, and irritation. The conversation covers the benefits of preservative-free drops in terms of improving patient compliance and minimizing ocular surface damage, which could potentially lead to fewer surgeries and better outcomes. They also share clinical experiences and highlight the barriers to transitioning patients to preservative-free medications, including issues related to cost, accessibility, and environmental waste. The episode concludes with an emphasis on the importance of collaboration among eye care providers to enhance patient care.
